[
    [
        {
            "time": "",
            "original_text": "白雲山取得開門紅！淨利潤大增37%，巨星品種滋腎育胎丸銷售增長超30%。",
            "features": {
                "keywords": [
                    "白雲山",
                    "開門紅",
                    "淨利潤",
                    "37%",
                    "滋腎育胎丸",
                    "銷售增長"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山取得開門紅！淨利潤大增37%，巨星品種滋腎育胎丸銷售增長超30%。",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "廣藥白雲山一季度營收突破200億元！巨星品種滋腎育胎丸銷售增長超30%。",
            "features": {
                "keywords": [
                    "廣藥白雲山",
                    "一季度",
                    "營收",
                    "200億元",
                    "滋腎育胎丸",
                    "銷售增長"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "廣藥白雲山一季度營收突破200億元！巨星品種滋腎育胎丸銷售增長超30%。",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "群益證券給予白雲山買進評級：21Q1淨利同比增長37%，為全年淨利增長奠定了良好的基礎。",
            "features": {
                "keywords": [
                    "群益證券",
                    "白雲山",
                    "買進評級",
                    "21Q1",
                    "淨利",
                    "同比增長",
                    "37%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "群益證券給予白雲山買進評級：21Q1淨利同比增長37%，為全年淨利增長奠定了良好的基礎。",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]